![Jeremy Lim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeremy Lim
Director Ejecutivo en AMILI Pte Ltd. .
Cargos activos de Jeremy Lim
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AMILI Pte Ltd.
![]() AMILI Pte Ltd. BiotechnologyHealth Technology AMILI Pte Ltd. is the world's largest multi-ethnic gut microbiota database and Southeast's first and only faecal microbiota transplant (FMT) bank. The company is based in Singapore, Singapore. The clinical research of the Singaporean company is focused on health and wellness, oncology, and response to microbiome-based therapeutics. AMILI offers a full suite of gut microbiome related services, ranging from study design, sample collection, processing, microbiome sequencing, and subsequent bioinformatics analysis. AMILI aims to advance microbiome research and apply this knowledge to improve human health. FMT preparations can be delivered via capsules, colonoscopies, nasoenteric tubes, and enemas. While AMILI currently only offers FMT preparations to be administered via colonoscopy, FMT preparations for alternative administration routes are in the pipeline. The company was founded by Jeremy Lim, who has been the CEO since incorporation. | Director Ejecutivo | - | - |
Fundador | - | - | |
HEAL Partners
![]() HEAL Partners Investment ManagersFinance HEAL Partners (HEAL Partners) is a venture capital firm founded in 2020. The firm is headquartered in Australia. | Consultor / Asesor | - | - |
Historial de carrera de Jeremy Lim
Formación de Jeremy Lim.
The Johns Hopkins University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 2 |
Australia | 2 |
Singapur | 2 |
Operativa
Chief Executive Officer | 1 |
Founder | 1 |
Consultant / Advisor | 1 |
Sectorial
Consumer Services | 2 |
Finance | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
HEAL Partners
![]() HEAL Partners Investment ManagersFinance HEAL Partners (HEAL Partners) is a venture capital firm founded in 2020. The firm is headquartered in Australia. | Finance |
AMILI Pte Ltd.
![]() AMILI Pte Ltd. BiotechnologyHealth Technology AMILI Pte Ltd. is the world's largest multi-ethnic gut microbiota database and Southeast's first and only faecal microbiota transplant (FMT) bank. The company is based in Singapore, Singapore. The clinical research of the Singaporean company is focused on health and wellness, oncology, and response to microbiome-based therapeutics. AMILI offers a full suite of gut microbiome related services, ranging from study design, sample collection, processing, microbiome sequencing, and subsequent bioinformatics analysis. AMILI aims to advance microbiome research and apply this knowledge to improve human health. FMT preparations can be delivered via capsules, colonoscopies, nasoenteric tubes, and enemas. While AMILI currently only offers FMT preparations to be administered via colonoscopy, FMT preparations for alternative administration routes are in the pipeline. The company was founded by Jeremy Lim, who has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Jeremy Lim
- Experiencia